APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Globulin Intravenous

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Immune Globulin Intravenous Industry Growth and Trends Forecast to 2032

22 December 2025100 pages

Choose your research edition.

Industry ResearchImmune Globulin Intravenous Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Globulin Intravenous Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Immune Globulin Intravenous Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Globulin Intravenous Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Globulin Intravenous Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Immune Globulin Intravenous market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immune Globulin Intravenous is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immune Globulin Intravenous is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Globulin Intravenous is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immune Globulin Intravenous include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immune Globulin Intravenous market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immune Globulin Intravenous market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immune Globulin Intravenous market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immune Globulin Intravenous.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Immune Globulin Intravenous market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immune Globulin Intravenous Market by Company

Takeda

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CNBG

CBPO

BPL

Biotest

Immune Globulin Intravenous Segment by Type

IVIg Liquid

IVIg Powder

Immune Globulin Intravenous Segment by Application

Acute Infection

Immunodeficiency

Autoimmune Disease

Immune Globulin Intravenous Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Globulin Intravenous market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Globulin Intravenous and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Globulin Intravenous.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immune Globulin Intravenous manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Immune Globulin Intravenous in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IVIg Liquid Table 2. Major Company of IVIg Powder Table 3. Global Immune Globulin Intravenous Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 5. Global Immune Globulin Intravenous Sales Market Share in Volume by Type (2021-2026) Table 6. Global Immune Globulin Intravenous Sales by Type (2021-2026) & (US$ Million) Table 7. Global Immune Globulin Intravenous Sales Market Share in Value by Type (2021-2026) Table 8. Global Immune Globulin Intravenous Price by Type (2021-2026) & (US$/unit) Table 9. Global Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 10. Global Immune Globulin Intravenous Sales Market Share in Volume by Type (2027-2032) Table 11. Global Immune Globulin Intravenous Sales by Type (2027-2032) & (US$ Million) Table 12. Global Immune Globulin Intravenous Sales Market Share in Value by Type (2027-2032) Table 13. Global Immune Globulin Intravenous Price by Type (2027-2032) & (US$/unit) Table 14. North America Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 15. North America Immune Globulin Intravenous Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 17. Europe Immune Globulin Intravenous Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Immune Globulin Intravenous Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 21. Latin America Immune Globulin Intravenous Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Immune Globulin Intravenous Sales by Type (2021-2026) & (US$ Million) Table 24. Immune Globulin Intravenous Industry Trends Table 25. Immune Globulin Intravenous Industry Drivers Table 26. Immune Globulin Intravenous Industry Opportunities and Challenges Table 27. Immune Globulin Intravenous Industry Restraints Table 28. Global Immune Globulin Intravenous Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Immune Globulin Intravenous Revenue Market Share by Company (2021-2026) Table 30. Global Immune Globulin Intravenous Sales by Company (2021-2026) & (units) Table 31. Global Immune Globulin Intravenous Sales Share by Company (2021-2026) Table 32. Global Immune Globulin Intravenous Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Immune Globulin Intravenous Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Immune Globulin Intravenous Major Company Production Sites and Headquarters Table 35. Global Immune Globulin Intravenous Company, Product Type & Application Table 36. Global Immune Globulin Intravenous Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Immune Globulin Intravenous by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Immune Globulin Intravenous Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Immune Globulin Intravenous Sales by Region (2021-2026) & (units) Table 41. Global Immune Globulin Intravenous Sales Market Share in Volume by Region (2021-2026) Table 42. Global Immune Globulin Intravenous Sales by Region (2021-2026) & (US$ Million) Table 43. Global Immune Globulin Intravenous Sales Market Share in Value by Region (2021-2026) Table 44. Global Immune Globulin Intravenous Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Immune Globulin Intravenous Sales by Region (2027-2032) & (units) Table 46. Global Immune Globulin Intravenous Sales Market Share in Volume by Region (2027-2032) Table 47. Global Immune Globulin Intravenous Sales by Region (2027-2032) & (US$ Million) Table 48. Global Immune Globulin Intravenous Sales Market Share in Value by Region (2027-2032) Table 49. Global Immune Globulin Intravenous Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Immune Globulin Intravenous Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 52. Global Immune Globulin Intravenous Sales Market Share in Volume by Application (2021-2026) Table 53. Global Immune Globulin Intravenous Sales by Application (2021-2026) & (US$ Million) Table 54. Global Immune Globulin Intravenous Sales Market Share in Value by Application (2021-2026) Table 55. Global Immune Globulin Intravenous Price by Application (2021-2026) & (US$/unit) Table 56. Global Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 57. Global Immune Globulin Intravenous Sales Market Share in Volume by Application (2027-2032) Table 58. Global Immune Globulin Intravenous Sales by Application (2027-2032) & (US$ Million) Table 59. Global Immune Globulin Intravenous Sales Market Share in Value by Application (2027-2032) Table 60. Global Immune Globulin Intravenous Price by Application (2027-2032) & (US$/unit) Table 61. North America Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 62. North America Immune Globulin Intravenous Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 64. Europe Immune Globulin Intravenous Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Immune Globulin Intravenous Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 68. Latin America Immune Globulin Intravenous Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Immune Globulin Intravenous Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Immune Globulin Intravenous Product Portfolio Table 75. Takeda Recent Development Table 76. Sichuan Yuanda Shuyang Company Information Table 77. Sichuan Yuanda Shuyang Business Overview Table 78. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio Table 80. Sichuan Yuanda Shuyang Recent Development Table 81. Shanghai RAAS Company Information Table 82. Shanghai RAAS Business Overview Table 83. Shanghai RAAS Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Shanghai RAAS Immune Globulin Intravenous Product Portfolio Table 85. Shanghai RAAS Recent Development Table 86. Hualan Bio Company Information Table 87. Hualan Bio Business Overview Table 88. Hualan Bio Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Hualan Bio Immune Globulin Intravenous Product Portfolio Table 90. Hualan Bio Recent Development Table 91. Octapharma Company Information Table 92. Octapharma Business Overview Table 93. Octapharma Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Octapharma Immune Globulin Intravenous Product Portfolio Table 95. Octapharma Recent Development Table 96. LFB Group Company Information Table 97. LFB Group Business Overview Table 98. LFB Group Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. LFB Group Immune Globulin Intravenous Product Portfolio Table 100. LFB Group Recent Development Table 101. Kedrion Company Information Table 102. Kedrion Business Overview Table 103. Kedrion Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Kedrion Immune Globulin Intravenous Product Portfolio Table 105. Kedrion Recent Development Table 106. Grifols Company Information Table 107. Grifols Business Overview Table 108. Grifols Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Grifols Immune Globulin Intravenous Product Portfolio Table 110. Grifols Recent Development Table 111. CSL Company Information Table 112. CSL Business Overview Table 113. CSL Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. CSL Immune Globulin Intravenous Product Portfolio Table 115. CSL Recent Development Table 116. CNBG Company Information Table 117. CNBG Business Overview Table 118. CNBG Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. CNBG Immune Globulin Intravenous Product Portfolio Table 120. CNBG Recent Development Table 121. CBPO Company Information Table 122. CBPO Business Overview Table 123. CBPO Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. CBPO Immune Globulin Intravenous Product Portfolio Table 125. CBPO Recent Development Table 126. BPL Company Information Table 127. BPL Business Overview Table 128. BPL Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. BPL Immune Globulin Intravenous Product Portfolio Table 130. BPL Recent Development Table 131. Biotest Company Information Table 132. Biotest Business Overview Table 133. Biotest Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Biotest Immune Globulin Intravenous Product Portfolio Table 135. Biotest Recent Development Table 136. North America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 137. North America Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 138. North America Immune Globulin Intravenous Sales Market Share by Country (2021-2026) Table 139. North America Immune Globulin Intravenous Sales Forecast by Country (2027-2032) & (units) Table 140. North America Immune Globulin Intravenous Sales Market Share Forecast by Country (2027-2032) Table 141. North America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Immune Globulin Intravenous Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Immune Globulin Intravenous Market Share by Country (2021-2026) Table 144. North America Immune Globulin Intravenous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Immune Globulin Intravenous Market Share Forecast by Country (2027-2032) Table 146. Europe Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 147. Europe Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 148. Europe Immune Globulin Intravenous Sales Market Share by Country (2021-2026) Table 149. Europe Immune Globulin Intravenous Sales Forecast by Country (2027-2032) & (units) Table 150. Europe Immune Globulin Intravenous Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Immune Globulin Intravenous Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Immune Globulin Intravenous Market Share by Country (2021-2026) Table 154. Europe Immune Globulin Intravenous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Immune Globulin Intravenous Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 158. Asia-Pacific Immune Globulin Intravenous Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Immune Globulin Intravenous Sales Forecast by Country (2027-2032) & (units) Table 160. Asia-Pacific Immune Globulin Intravenous Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Immune Globulin Intravenous Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Immune Globulin Intravenous Market Share by Country (2021-2026) Table 164. Asia-Pacific Immune Globulin Intravenous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Immune Globulin Intravenous Market Share Forecast by Country (2027-2032) Table 166. Latin America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 167. Latin America Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 168. Latin America Immune Globulin Intravenous Sales Market Share by Country (2021-2026) Table 169. Latin America Immune Globulin Intravenous Sales Forecast by Country (2027-2032) & (units) Table 170. Latin America Immune Globulin Intravenous Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Immune Globulin Intravenous Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Immune Globulin Intravenous Market Share by Country (2021-2026) Table 174. Latin America Immune Globulin Intravenous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Immune Globulin Intravenous Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 178. Middle East and Africa Immune Globulin Intravenous Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Immune Globulin Intravenous Sales Forecast by Country (2027-2032) & (units) Table 180. Middle East and Africa Immune Globulin Intravenous Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Immune Globulin Intravenous Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Immune Globulin Intravenous Market Share by Country (2021-2026) Table 184. Middle East and Africa Immune Globulin Intravenous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Immune Globulin Intravenous Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Immune Globulin Intravenous Distributors List Table 189. Immune Globulin Intravenous Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Immune Globulin Intravenous Image Figure 2. Global Immune Globulin Intravenous Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Globulin Intravenous Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune Globulin Intravenous Sales (2021-2032) & (units) Figure 5. IVIg Liquid Image Figure 6. Global IVIg Liquid Sales YoY Growth (2021-2032) & (units) Figure 7. IVIg Powder Image Figure 8. Global IVIg Powder Sales YoY Growth (2021-2032) & (units) Figure 9. Global Immune Globulin Intravenous Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Immune Globulin Intravenous Market Share by Type 2025 VS 2032 Figure 11. North America Immune Globulin Intravenous Sales Market Share in Volume by Type in 2025 Figure 12. North America Immune Globulin Intravenous Sales Market Share in Value by Type in 2025 Figure 13. Europe Immune Globulin Intravenous Sales Market Share in Volume by Type in 2025 Figure 14. Europe Immune Globulin Intravenous Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Value by Type in 2025 Figure 17. Latin America Immune Globulin Intravenous Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Immune Globulin Intravenous Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Immune Globulin Intravenous Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Acute Infection Image Figure 24. Global Acute Infection Sales YoY Growth (2021-2032) & (units) Figure 25. Immunodeficiency Image Figure 26. Global Immunodeficiency Sales YoY Growth (2021-2032) & (units) Figure 27. Autoimmune Disease Image Figure 28. Global Autoimmune Disease Sales YoY Growth (2021-2032) & (units) Figure 29. Global Immune Globulin Intravenous Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Immune Globulin Intravenous Market Share by Application 2025 VS 2032 Figure 31. North America Immune Globulin Intravenous Sales Market Share in Volume by Application in 2025 Figure 32. North America Immune Globulin Intravenous Sales Market Share in Value by Application in 2025 Figure 33. Europe Immune Globulin Intravenous Sales Market Share in Volume by Application in 2025 Figure 34. Europe Immune Globulin Intravenous Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Immune Globulin Intravenous Sales Market Share in Value by Application in 2025 Figure 37. Latin America Immune Globulin Intravenous Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Immune Globulin Intravenous Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Immune Globulin Intravenous Sales Market Share in Value by Application in 2025 Figure 41. North America Immune Globulin Intravenous Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 42. North America Immune Globulin Intravenous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Immune Globulin Intravenous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Immune Globulin Intravenous Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Immune Globulin Intravenous Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 46. Europe Immune Globulin Intravenous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Immune Globulin Intravenous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Immune Globulin Intravenous Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Immune Globulin Intravenous Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 50. Asia-Pacific Immune Globulin Intravenous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Immune Globulin Intravenous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Immune Globulin Intravenous Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Immune Globulin Intravenous Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 54. Latin America Immune Globulin Intravenous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Immune Globulin Intravenous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Immune Globulin Intravenous Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Immune Globulin Intravenous Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 58. Middle East and Africa Immune Globulin Intravenous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Immune Globulin Intravenous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Immune Globulin Intravenous Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Immune Globulin Intravenous Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Immune Globulin Intravenous Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Acute Infection
  • Immunodeficiency
  • Autoimmune Disease
Companies covered
  • Takeda
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CNBG
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immune Globulin Intravenous Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Immune Globulin Intravenous Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Immune Globulin Intravenous Market by Type
  6. 1.3.1 IVIg Liquid
  7. 1.3.2 IVIg Powder
  8. 1.4 Global Immune Globulin Intravenous Market Size by Type
  9. 1.4.1 Global Immune Globulin Intravenous Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Immune Globulin Intravenous Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Immune Globulin Intravenous Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Immune Globulin Intravenous Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Immune Globulin Intravenous Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Immune Globulin Intravenous Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Immune Globulin Intravenous Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Immune Globulin Intravenous Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Immune Globulin Intravenous Industry Trends
  2. 2.2 Immune Globulin Intravenous Industry Drivers
  3. 2.3 Immune Globulin Intravenous Industry Opportunities and Challenges
  4. 2.4 Immune Globulin Intravenous Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Immune Globulin Intravenous Revenue (2021-2026)
  2. 3.2 Global Top Players by Immune Globulin Intravenous Sales (2021-2026)
  3. 3.3 Global Top Players by Immune Globulin Intravenous Price (2021-2026)
  4. 3.4 Global Immune Globulin Intravenous Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immune Globulin Intravenous Major Company Production Sites & Headquarters
  6. 3.6 Global Immune Globulin Intravenous Company, Product Type & Application
  7. 3.7 Global Immune Globulin Intravenous Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immune Globulin Intravenous Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immune Globulin Intravenous Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immune Globulin Intravenous Tier 1, Tier 2, and Tier 3
4 Immune Globulin Intravenous Regional Status and Outlook
  1. 4.1 Global Immune Globulin Intravenous Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Immune Globulin Intravenous Historic Market Size by Region
  3. 4.2.1 Global Immune Globulin Intravenous Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Immune Globulin Intravenous Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Immune Globulin Intravenous Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Immune Globulin Intravenous Forecasted Market Size by Region
  7. 4.3.1 Global Immune Globulin Intravenous Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Immune Globulin Intravenous Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Immune Globulin Intravenous Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immune Globulin Intravenous by Application
  1. 5.1 Immune Globulin Intravenous Market by Application
  2. 5.1.1 Acute Infection
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Autoimmune Disease
  5. 5.2 Global Immune Globulin Intravenous Market Size by Application
  6. 5.2.1 Global Immune Globulin Intravenous Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Immune Globulin Intravenous Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Immune Globulin Intravenous Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Immune Globulin Intravenous Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Immune Globulin Intravenous Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Immune Globulin Intravenous Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Immune Globulin Intravenous Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Immune Globulin Intravenous Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Immune Globulin Intravenous Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sichuan Yuanda Shuyang
  8. 6.2.1 Sichuan Yuanda Shuyang Company Information
  9. 6.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 6.2.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio
  12. 6.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 6.3 Shanghai RAAS
  14. 6.3.1 Shanghai RAAS Company Information
  15. 6.3.2 Shanghai RAAS Business Overview
  16. 6.3.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai RAAS Immune Globulin Intravenous Product Portfolio
  18. 6.3.5 Shanghai RAAS Recent Developments
  19. 6.4 Hualan Bio
  20. 6.4.1 Hualan Bio Company Information
  21. 6.4.2 Hualan Bio Business Overview
  22. 6.4.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Bio Immune Globulin Intravenous Product Portfolio
  24. 6.4.5 Hualan Bio Recent Developments
  25. 6.5 Octapharma
  26. 6.5.1 Octapharma Company Information
  27. 6.5.2 Octapharma Business Overview
  28. 6.5.3 Octapharma Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Octapharma Immune Globulin Intravenous Product Portfolio
  30. 6.5.5 Octapharma Recent Developments
  31. 6.6 LFB Group
  32. 6.6.1 LFB Group Company Information
  33. 6.6.2 LFB Group Business Overview
  34. 6.6.3 LFB Group Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 LFB Group Immune Globulin Intravenous Product Portfolio
  36. 6.6.5 LFB Group Recent Developments
  37. 6.7 Kedrion
  38. 6.7.1 Kedrion Company Information
  39. 6.7.2 Kedrion Business Overview
  40. 6.7.3 Kedrion Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kedrion Immune Globulin Intravenous Product Portfolio
  42. 6.7.5 Kedrion Recent Developments
  43. 6.8 Grifols
  44. 6.8.1 Grifols Company Information
  45. 6.8.2 Grifols Business Overview
  46. 6.8.3 Grifols Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Grifols Immune Globulin Intravenous Product Portfolio
  48. 6.8.5 Grifols Recent Developments
  49. 6.9 CSL
  50. 6.9.1 CSL Company Information
  51. 6.9.2 CSL Business Overview
  52. 6.9.3 CSL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CSL Immune Globulin Intravenous Product Portfolio
  54. 6.9.5 CSL Recent Developments
  55. 6.10 CNBG
  56. 6.10.1 CNBG Company Information
  57. 6.10.2 CNBG Business Overview
  58. 6.10.3 CNBG Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CNBG Immune Globulin Intravenous Product Portfolio
  60. 6.10.5 CNBG Recent Developments
  61. 6.11 CBPO
  62. 6.11.1 CBPO Company Information
  63. 6.11.2 CBPO Business Overview
  64. 6.11.3 CBPO Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CBPO Immune Globulin Intravenous Product Portfolio
  66. 6.11.5 CBPO Recent Developments
  67. 6.12 BPL
  68. 6.12.1 BPL Company Information
  69. 6.12.2 BPL Business Overview
  70. 6.12.3 BPL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BPL Immune Globulin Intravenous Product Portfolio
  72. 6.12.5 BPL Recent Developments
  73. 6.13 Biotest
  74. 6.13.1 Biotest Company Information
  75. 6.13.2 Biotest Business Overview
  76. 6.13.3 Biotest Immune Globulin Intravenous Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Biotest Immune Globulin Intravenous Product Portfolio
  78. 6.13.5 Biotest Recent Developments
7 North America by Country
  1. 7.1 North America Immune Globulin Intravenous Sales by Country
  2. 7.1.1 North America Immune Globulin Intravenous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Immune Globulin Intravenous Sales by Country (2021-2026)
  4. 7.1.3 North America Immune Globulin Intravenous Sales Forecast by Country (2027-2032)
  5. 7.2 North America Immune Globulin Intravenous Market Size by Country
  6. 7.2.1 North America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Immune Globulin Intravenous Market Size by Country (2021-2026)
  8. 7.2.3 North America Immune Globulin Intravenous Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Immune Globulin Intravenous Sales by Country
  2. 8.1.1 Europe Immune Globulin Intravenous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Immune Globulin Intravenous Sales by Country (2021-2026)
  4. 8.1.3 Europe Immune Globulin Intravenous Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Immune Globulin Intravenous Market Size by Country
  6. 8.2.1 Europe Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Immune Globulin Intravenous Market Size by Country (2021-2026)
  8. 8.2.3 Europe Immune Globulin Intravenous Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Immune Globulin Intravenous Sales by Country
  2. 9.1.1 Asia-Pacific Immune Globulin Intravenous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Immune Globulin Intravenous Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Immune Globulin Intravenous Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Immune Globulin Intravenous Market Size by Country
  6. 9.2.1 Asia-Pacific Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Immune Globulin Intravenous Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Immune Globulin Intravenous Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Immune Globulin Intravenous Sales by Country
  2. 10.1.1 South America Immune Globulin Intravenous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Immune Globulin Intravenous Sales by Country (2021-2026)
  4. 10.1.3 South America Immune Globulin Intravenous Sales Forecast by Country (2027-2032)
  5. 10.2 South America Immune Globulin Intravenous Market Size by Country
  6. 10.2.1 South America Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Immune Globulin Intravenous Market Size by Country (2021-2026)
  8. 10.2.3 South America Immune Globulin Intravenous Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Immune Globulin Intravenous Sales by Country
  2. 11.1.1 Middle East and Africa Immune Globulin Intravenous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Immune Globulin Intravenous Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Immune Globulin Intravenous Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Immune Globulin Intravenous Market Size by Country
  6. 11.2.1 Middle East and Africa Immune Globulin Intravenous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Immune Globulin Intravenous Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Immune Globulin Intravenous Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Immune Globulin Intravenous Value Chain Analysis
  2. 12.1.1 Immune Globulin Intravenous Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Immune Globulin Intravenous Production Mode & Process
  7. 12.2 Immune Globulin Intravenous Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Immune Globulin Intravenous Distributors
  10. 12.2.3 Immune Globulin Intravenous Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst